FOXP1 and breast cancer: Therefore, we have focused on miRNAs targeting iR and Foxp1 gene expression in CD8+ T cells in murine 4T1 breast cancer cells in vitro; our data reveal that an miRNA has the capacity to enhance antitumour immunity by reversing CD8+ T-cell exhaustion.